首页> 外文期刊>journal of antimicrobial chemotherapy >Treatment of urinary tract infections in general practice with sulfamethizole, trimethoprim or co-trimazine (sulphadiazine-trimethoprim)
【24h】

Treatment of urinary tract infections in general practice with sulfamethizole, trimethoprim or co-trimazine (sulphadiazine-trimethoprim)

机译:Treatment of urinary tract infections in general practice with sulfamethizole, trimethoprim or co-trimazine (sulphadiazine-trimethoprim)

获取原文
           

摘要

In a double-blind investigation of urinary tract infections in general practice the effects of sulphamethizole, trimethoprim and sulphadiazine-trimethoprim (co-trimazine) were compared.The investigation was conducted as a multi-practice study with the participation of 314 general practitioners. A total of 965 patients were treated and followed up. The results, evaluated by urine culture 2 weeks after commencement of treatment, showed that sterile urine was obtained in 68.5of the patients treated with sulphamethizole, in 78.9of those treated with trimethoprim, and in 83.3of those treated with co-trimazine. Skin reactions occurred with sulphamethizole in 1.4with trimethoprim in 4.1, and with sulphadiazine-trimethoprim in 3.2.We believe that rapidly excreted sulphonamides should continue to be preferred as drugs of first choice in the treatment of urinary tract infections in general practice, but that the use of trimethoprim or the combination sulphadiazine-trimethoprim is a worthwhile alternative to sulphonamide treatment, particularly for elderly patients and patients infected with sulphonamide-resistant bacteria.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号